Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance

Highly active antiretroviral (ARV) therapy has been used for many years, but the use in low- and middle-income countries of antiretroviral drugs with low genetic barrier to resistance, combined with limited availability of viral load testing, has led to higher rates of acquired drug resistance, sust...

Descripción completa

Detalles Bibliográficos
Autores principales: Charpentier, Charlotte, Le Hingrat, Quentin, Ferré, Valentine Marie, Damond, Florence, Descamps, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967014/
https://www.ncbi.nlm.nih.gov/pubmed/36851754
http://dx.doi.org/10.3390/v15020540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967014/
https://www.ncbi.nlm.nih.gov/pubmed/36851754
http://dx.doi.org/10.3390/v15020540

Ejemplares similares